A compound with the SMILES CN(CC(=O)N1CCN(c2ccc(F)cc2)CC1)S(=O)(=O)c1ccc2c(c1)c(=O)n(C)c(=O)n2C has a hERG inhibition at a concentration of 1uM of 8.985\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CN(CC(=O)N1CCN(c2ccc(F)cc2)CC1)S(=O)(=O)c1ccc2c(c1)c(=O)n(C)c(=O)n2C
CN(CC(=O)N1CCN(c2ccc(F)cc2)CC1)S(=O)(=O)c1ccc2c(c1)c(=O)n(C)c(=O)n2C
N-[2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl]-N,1,3-trimethyl-2,4-dioxoquinazoline-6-sulfonamide